6505--Venlafaxine 24HR Sustained Action Capsules

The solicitation requires offerors to submit a detailed subcontracting plan that complies with FAR 52.219‑9, Public Law 95‑507, and VAAR 852.219‑70. Offerors must justify any proposed goals that are lower than the VA‑suggested or prior‑year achieved goals, identify specific potential sources (websites, associations, events, etc.), and indicate whether indirect costs are included in the dollar and percentage goals. Separate dollar and percentage goals must be provided for each contract option period, and the plan must cover the entire performance period (or align with the company’s fiscal year for commercial plans). The plan must also describe good‑faith, internal and external efforts to ensure equitable opportunities for small, veteran‑owned, HUBZone, disadvantaged, and women‑owned businesses, and include a designated program administrator with comprehensive duties, including timely eSRS reporting and plan renewal 30 days before expiration. In addition, offerors must disclose the name and address of the manufacturing facility (or indicate distributor status) and provide evidence of substantial transformation, API details, and cGMP compliance. All covered drug products/NDCs must be on the offeror’s FSS contract or interim agreement with a permanent FCP by the offer deadline, otherwise the offer will be rejected. Finally, contractors are required to submit quarterly sales reports and remit cost‑recovery fees in U.S. dollars, rounded to the nearest whole dollar, for each calendar quarter.

Notice ID

d0515cb238ce49c49fcb317e3134ada8

Solicitation Number

36E79726R0010

NAICS Code

325412

Classification Code

6505